Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.
2.

[25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].

Tattersall RB.

Journ Annu Diabetol Hotel Dieu. 1984:183-91. Review. French. No abstract available.

PMID:
6443219
3.

[Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].

Kadota I.

Nihon Rinsho. 1969 Aug;27(8):2136-50. Review. Japanese. No abstract available.

PMID:
4901777
4.

Insulin-independent diabetes mellitus.

Bricker LA, Mintz DH.

Med Clin North Am. 1971 Mar;55(2):295-304. Review. No abstract available.

PMID:
4926053
5.

Antidiabetic agents and vascular events.

Keen H.

J Clin Pathol Suppl (R Coll Pathol). 1975;9:99-105. Review. No abstract available.

6.

Metabolic considerations in the treatment of juvenile diabetes mellitus.

Bacon GE, Parkhurst RD.

Med Clin North Am. 1969 Nov;53(6):1367-78. Review. No abstract available.

PMID:
4982939
7.

Hypoglycemic drugs.

Stehling L.

Clin Anesth. 1974;10(1):233-47. Review. No abstract available.

PMID:
4598996
8.

Pharmacological intervention: the antidiabetic approach.

Melander A.

Eur J Clin Invest. 1998 Sep;28 Suppl 2:23-5; discussion 25-6. Review.

PMID:
9777324
9.

The use of ACE inhibitors on diabetic patients without renal disease.

Kirpichnikov D, Winer N, Sowers JR.

Curr Diab Rep. 2002 Feb;2(1):21-5. Review.

PMID:
12643119
10.

Vascular disease and lipids in diabetes.

Garber AJ.

Med Clin North Am. 1998 Jul;82(4):931-48. Review.

PMID:
9706127
11.

Prevention of type 2 diabetes.

Goldberg RB.

Med Clin North Am. 1998 Jul;82(4):805-21. Review.

PMID:
9706122
12.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
13.

Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus.

Langer O.

Diabetes Care. 1998 Aug;21 Suppl 2:B91-8. Review.

PMID:
9704234
14.

Glucose and insulin management in the post-MI setting.

McNulty PH.

Curr Diab Rep. 2002 Feb;2(1):37-44. Review.

PMID:
12643121
15.

Cardiovascular effects of insulin sensitizers in diabetes.

Jawa A, Fonseca V.

Curr Opin Investig Drugs. 2006 Sep;7(9):806-14. Review.

PMID:
17002258
16.

Medical hypothesis: cardiovascular complications of diabetes mellitus-from glucose to insulin and back.

Giugliano D, Acampora R, D'Onofrio F.

Diabete Metab. 1994 Sep-Oct;20(5):445-53. Review.

PMID:
7859891
17.

Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.

Bethel MA, Sourij H.

Curr Cardiol Rep. 2012 Feb;14(1):59-69. doi: 10.1007/s11886-011-0229-7. Review.

PMID:
22094711
18.

Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.

Nosadini R, Abaterusso C, Dalla Vestra M, Bortoloso E, Saller A, Bruseghin M, Sfriso A, Trevisan M.

Nephrol Dial Transplant. 1998;13 Suppl 8:44-8. Review.

PMID:
9870425
19.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
20.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124

Supplemental Content

Support Center